As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.
about
Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men.Hyperuricemia and cardiovascular disease risk.Impact of Urate Level on Cardiovascular Risk in Allopurinol Treated Patients. A Nested Case-Control StudyEffects of Allopurinol on Arterial Stiffness: A Meta-Analysis of Randomized Controlled TrialsEffects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricemia.[Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].Febuxostat improves outcome in a rat model of cancer cachexia.Effects of xanthine oxidase inhibition with febuxostat on the development of nephropathy in experimental type 2 diabetes.Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease.Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials.Langfassung zur S2e-Leitlinie Gichtarthritis (fachärztlich)Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis
P2860
Q34029936-2EE304A6-E472-4FE5-A9AD-EC336C874CD2Q34437057-D719F4F4-25D9-4ED7-990B-9DC8A60EE0A7Q35889954-8B753B0A-9092-4B68-B8AB-69E4A999DF0AQ35998065-D4B43BCD-AC52-4E6C-95C4-2107433C997EQ36331121-5C6C7941-FDD6-4EFC-8C60-827E4BBF3792Q41746637-3886726B-FD6E-46DE-9A21-1799721807FFQ41769219-7DEB828F-530C-4B5E-9D4B-1BE8A3FD8C0AQ41974155-2F5FCF6A-4B4E-4861-BC87-845C9F4B6E89Q47690427-E279CB75-D72C-42C9-B7B6-6DFA463540F7Q49584618-99FD8D33-5A81-4081-8141-521BDB95550CQ56637250-92973534-1192-4D14-B195-587BDC152E15Q57170834-EDC39B81-DF3D-441E-8422-13348FCE8708
P2860
As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
As compared to allopurinol, ur ...... evere chronic tophaceous gout.
@en
As compared to allopurinol, ur ...... evere chronic tophaceous gout.
@nl
type
label
As compared to allopurinol, ur ...... evere chronic tophaceous gout.
@en
As compared to allopurinol, ur ...... evere chronic tophaceous gout.
@nl
prefLabel
As compared to allopurinol, ur ...... evere chronic tophaceous gout.
@en
As compared to allopurinol, ur ...... evere chronic tophaceous gout.
@nl
P2093
P2860
P1476
As compared to allopurinol, ur ...... evere chronic tophaceous gout.
@en
P2093
A-K Tausche
C Wunderlich
M Christoph
M Forkmann
S Kopprasch
P2860
P2888
P304
P356
10.1007/S00296-013-2857-2
P577
2013-09-12T00:00:00Z
P6179
1049543373